Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99.3M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
389K
-
Shares change
-
-289K
-
Total reported value, excl. options
-
$369K
-
Value change
-
-$388K
-
Number of buys
-
10
-
Number of sells
-
-3
-
Price
-
$0.95
Significant Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) as of Q1 2025
17 filings reported holding PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value as of Q1 2025.
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 389K shares
of 99.3M outstanding shares and own 0.39% of the company stock.
Largest 10 shareholders include HRT FINANCIAL LP (102K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (80.5K shares), GEODE CAPITAL MANAGEMENT, LLC (57.1K shares), Virtu Financial LLC (40K shares), UBS Group AG (33.4K shares), VANGUARD GROUP INC (32.5K shares), Ground Swell Capital, LLC (13.7K shares), TWO SIGMA SECURITIES, LLC (13.6K shares), Tower Research Capital LLC (TRC) (7.68K shares), and BlackRock, Inc. (6.96K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.